1. Aberrant promoter CpG methylation and its translational applications in breast cancer. |
Page:12—20 |
2. Epigenetic changes in colorectal cancer. |
Page:21—30 |
3. Recent progress in the study of methylated tumor suppressor genes in gastric cancer. |
Page:31—41 |
4. Impact of genetic alterations on mTOR-targeted cancer therapy. |
Page:270—274 |
5. Liver cancer incidence and mortality in China, 2009. |
Page:162—169 |
6. Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery. |
Page:403—409 |
7. Malignant meningioma of the cerebellopontine angle in a 2-year-old girl: a case report and literature review. |
Page:415—417 |
8. Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells. |
Page:553—560 |
9. The incidences and mortalities of major cancers in China, 2009. |
Page:106—112 |
10. Pluripotency transcription factors and cancer stem cells: small genes make a big difference. |
Page:483—487 |
11. The VEGF signaling pathway in cancer: the road ahead. |
Page:297—302 |
12. Müllerian duct anomalies and their effect on the radiotherapeutic management of cervical cancer. |
Page:434—440 |
13. Autophagy and apoptosis: rivals or mates? |
Page:103—105 |
14. Hodgkin's lymphoma involving extranodal sites: potential association with HIV infection and the implications for clinical management. |
Page:102—102 |
15. Molecular markers as therapeutic targets in lung cancer. |
Page:59—62 |
16. Identification of SNP-containing regulatory motifs in the myelodysplastic syndromes model using SNP arrays and gene expression arrays. |
Page:170—185 |
17. B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium. |
Page:653—660 |
18. Skeletal metastasis: treatments, mouse models, and the Wnt signaling. |
Page:380—396 |
19. The Sino-French 2012 Conference in Thoracic Oncology: an international academic platform for in-depth exchange on comprehensive research. |
Page:53—58 |
20. Small interfering RNA-based molecular therapy of cancers. |
Page:488—493 |
21. Mouse models of Mdm2 and Mdm4 and their clinical implications. |
Page:371—375 |
22. Discovery of molecular associations among aging, stem cells, and cancer based on gene expression profiling. |
Page:155—161 |
23. Complications of radical nephrectomy for renal cell carcinoma: a retrospective study comparing transperitoneal and retroperitoneal approaches using a standardized reporting methodology in two Chinese centers. |
Page:461—468 |
24. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. |
Page:312—324 |
25. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with conventional beams for nasopharyngeal carcinoma: a feasibility study. |
Page:397—402 |
26. Small nucleolar RNAs (snoRNAs) as potential non-invasive biomarkers for early cancer detection. |
Page:99—101 |
27. The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China. |
Page:410—414 |
28. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer. |
Page:441—452 |
29. Using the theory of coevolution to predict protein-protein interactions in non-small cell lung cancer. |
Page:91—98 |
30. Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study. |
Page:325—333 |
31. Glioma-related edema: new insight into molecular mechanisms and their clinical implications. |
Page:49—52 |
32. Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment. |
Page:353—356 |
33. Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. |
Page:303—311 |
34. The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations. |
Page:136—140 |
35. Detection and characterization of regulatory elements using probabilistic conditional random field and hidden Markov models. |
Page:186—194 |
36. GOMA: functional enrichment analysis tool based on GO modules. |
Page:195—204 |
37. Regulation of tumor cell migration by protein tyrosine phosphatase (PTP)-proline-, glutamate-, serine-,and threonine-rich sequence (PEST). |
Page:75—83 |
38. Dynamic protein-protein interaction subnetworks of lung cancer in cases with smoking history. |
Page:84—90 |
39. Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006. |
Page:512—519 |
40. The role of stem cells in airway repair: implications for the origins of lung cancer. |
Page:71—74 |
41. The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system. |
Page:342—352 |
42. The cellular decision between apoptosis and autophagy. |
Page:121—129 |
43. Managing esophageal fistulae by endoscopic transluminal drainage in esophageal cancer patients with superior mediastinal sepsis after esophagectomy. |
Page:469—473 |
44. Favorable prognosis of female patients with nasopharyngeal carcinoma. |
Page:283—288 |
45. Retroperitoneal schwannoma mimicking metastatic seminoma: case report and literature review. |
Page:149—152 |
46. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer. |
Page:289—296 |
47. Efficacy of minimally invasive therapies on unresectable pancreatic cancer. |
Page:334—341 |
48. Aberrant DNA methylation in cervical carcinogenesis. |
Page:42—48 |
49. Role of autophagy in acute myeloid leukemia therapy. |
Page:130—135 |
50. Targeting autophagic pathways for cancer drug discovery. |
Page:113—120 |
51. Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients. |
Page:213—223 |
52. The genetics and biology of KRAS in lung cancer. |
Page:63—70 |
53. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma. |
Page:141—148 |
54. The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability. |
Page:205—212 |
55. Assessment of quality of life for the patients with cervical cancer at different clinical stages. |
Page:275—282 |
56. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma. |
Page:3—11 |
57. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis. |
Page:604—613 |
58. Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment. |
Page:594—603 |
59. Noncoding RNAs in cancer and cancer stem cells. |
Page:582—593 |
60. Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. |
Page:573—581 |
61. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma. |
Page:525—532 |
62. Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer. |
Page:539—545 |
63. Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. |
Page:494—501 |
64. An early history of human breast cancer: West meets East. |
Page:475—477 |
65. Nasopharyngeal carcinoma incidence and mortality in China in 2009. |
Page:453—460 |
66. The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies. |
Page:478—482 |
67. Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment. |
Page:546—552 |
68. Targeted therapy: tailoring cancer treatment. |
Page:363—364 |
69. Translational research in oncology research & development and its impact on early development in China: report of the 5th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at 2013 AACR Annual Meeting. |
Page:357—362 |
70. Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma. |
Page:502—511 |
71. Ubiquitin at the crossroad of cell death and survival. |
Page:640—647 |
72. Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis. |
Page:533—538 |
73. Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease. |
Page:673—677 |
74. The prognostic role of PRUNE2 in leiomyosarcoma. |
Page:648—652 |
75. Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies. |
Page:661—666 |
76. Investigating evolutionary perspective of carcinogenesis with single-cell transcriptome analysis. |
Page:636—639 |
77. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance. |
Page:365—370 |
78. Clinical implications of microRNAs in liver cancer stem cells. |
Page:419—426 |
79. Intraarterial chemotherapy with gemcitabine and cisplatin in locally advanced or recurrent penile squamous cell carcinoma. |
Page:619—623 |
80. Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy. |
Page:376—379 |
81. Urinary bladder malignant paraganglioma with vertebral metastasis: a case report with literature review. |
Page:624—628 |
82. Dysregulation of mTOR activity through LKB1 inactivation. |
Page:427—433 |
83. Targeting the PI3K-AKT-mTOR signaling network in cancer. |
Page:253—265 |
84. Molecular targeted agents--where we are and where we are going. |
Page:225—232 |
85. Centrifugation: an important pre-analytic procedure that influences plasma microRNA quantification during blood processing. |
Page:667—672 |
86. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. |
Page:614—618 |
87. Biological functions of decorin in cancer. |
Page:266—269 |
88. IGF-1R as an anti-cancer target--trials and tribulations. |
Page:242—252 |
89. Cancer research in an era when epigenetics is no longer "epi" - challenges and opportunities. |
Page:1—2 |
90. Cancer bioinformatics: detection of chromatin states, SNP-containing motifs, and functional enrichment modules. |
Page:153—154 |
91. A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer. |
Page:567—570 |
92. A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin. |
Page:520—523 |
93. Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases. |
Page:561—566 |
94. sMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma. |
Page:224—224 |
95. New evidence-based adaptive clinical trial methods for optimally integrating predictive biomarkers into oncology clinical development programs. |
Page:233—241 |